Indiana University-Bren and Melvin Simon Cancer Center — Indianapolis, Indiana

Indiana University-Bren and Melvin Simon Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

Indiana University-Bren and Melvin Simon Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Recurrent Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma.

Sponsors: Tracon Pharmaceuticals Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University-Bren and Melvin Simon Cancer Center?

Indiana University-Bren and Melvin Simon Cancer Center has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University-Bren and Melvin Simon Cancer Center conducted?

Indiana University-Bren and Melvin Simon Cancer Center has 1 clinical trials on record. Their work covers Recurrent Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma.

Is Indiana University-Bren and Melvin Simon Cancer Center accredited by Crixeo Clinical Trials?

Indiana University-Bren and Melvin Simon Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana University-Bren and Melvin Simon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.